Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000208407 | SCV000264314 | uncertain significance | Long QT syndrome | 2015-06-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001853319 | SCV002296308 | uncertain significance | Dilated cardiomyopathy 1W | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002347816 | SCV002652378 | uncertain significance | Cardiovascular phenotype | 2022-06-02 | criteria provided, single submitter | clinical testing | The p.V189M variant (also known as c.565G>A), located in coding exon 5 of the VCL gene, results from a G to A substitution at nucleotide position 565. The valine at codon 189 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. |